ZLAB News and Press, Zai Lab Limited From 05/08/25

– Total revenues grew 22% y-o-y to $106.5 million for the first quarter of 2025; reaffirming full-year 2025 revenue guidance of $560 million to $590 million – Operating loss improved significantly, declining 20% year-over-year to $56.3 million for the first quarter of ...

2025-05-07 11:17:26 ET More on Zai Lab Zai Lab: Innovative Pharma Set For Strong Year Of Business (And Share Price) Growth Zai Lab: Still Attractive Despite Higher Costs And Added Trade War Risks Zai Lab Limited (ZLAB) Q4 2024 Earnings Call Transcript Zai Lab...

2025-04-28 08:09:00 ET Summary Baron Emerging Markets Fund increased in the first quarter of 2025, outperforming its benchmark, the MSCI EM Index. Emerging markets equities outperformed as the uncertainty generated by Trump’s tariff war spurred a broad-based rotation out of...

- Findings support advancement of ZL-6201 into Investigational New Drug (IND)-enabling studies in 2025 as a potential first-in-class and best-in-class antibody-drug conjugate (ADC) treatment for patients with leucine-rich repeat-containing protein 15 (LRRC15)-positive solid tumors - Dat...

- Zai Lab will highlight potential of ZL-1310 as a promising, best-in-class Delta-like ligand (DLL3-targeted) ADC for patients with extensive-stage small cell lung cancer (ES-SCLC) - Investor conference call and webcast to discuss data and clinical trial plans on June 2, 2025, at 7:00 a...

2025-04-21 09:33:27 ET More on Zai Lab Zai Lab: Innovative Pharma Set For Strong Year Of Business (And Share Price) Growth Zai Lab: Still Attractive Despite Higher Costs And Added Trade War Risks Zai Lab Limited (ZLAB) Q4 2024 Earnings Call Transcript Genmab ...

Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced that China’s National Medical Products Administration (NMPA) has accepted the supplemental New Drug Application (sNDA) for repotrectinib for the treatment of adult patients with solid tumors that harbor a neurotrophic tyrosine rece...

2025-04-17 05:00:00 ET Summary Donald Trump has exempted reciprocal tariffs on certain electronic Chinese imports, giving markets a slight reprieve as the U.S.-China trade war heats up. While tariffs are likely to burn both countries, China could be in a stronger position to repla...

- Company to host conference call and webcast on May 8, 2025, at 8:00 a.m. ET (8:00 p.m. HKT) Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced that it will report its first quarter 2025 financial results and provide recent corporate updates on May 8, 2025, before the openi...

2025-04-03 18:16:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...